Medior

Medior

Antiviral/Covid-19 Therapy

Print
View on GoToCrowd
Security Type
Debt/Note
Min Investment
$100
Location
Del Mar, CA
Offering Date
January 12, 2021
Expected Close Date
December 31, 2021
Target Raise
$50.00K-$1.00M
Deal Notes

Pro-rata portion of total principal value raised; Notes will be sold in increments of $1.00 with a minimum investment of $100.00.

Company Description

About Medior is a biosciences company seeking to repurpose existing antiviral medications to treat SARS-CoV-2 (Covid-19). We are working on modifications in delivery format to use a known therapy to combat a novel virus. Reasons to Invest New drug development takes years and substantial capital investment; Repurposing existing therapies is faster and a fraction of the...

Deal Notes

Pro-rata portion of total principal value raised; Notes will be sold in increments of $1.00 with a minimum investment of $100.00.

Amount Raised : $0
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A note is a financial security that generally has a longer term than a bill but a shorter term than a bond.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment